as no differences were revealed between the urinary levels of hydrocortisone ( f ) , cortisone ( e ) , tetrahydro-ii-desoxyhydrocortisone ( tht ) in pcai patients treated with cortisone acetate and in normals the author suggested selecting the supportive dosages of cortisone acetate with regard to the assessment of f , e , and tht concentrations ( except for the cases of suprarenal crisis ) .
C0010137
cortisone
C0056391
cortisone acetate